A new Scripps Research study highlights the link between heavy alcohol use and the acceleration of Alzheimer’s disease.
Lecanemab is the first treatment for Alzheimer’s disease licensed for use in Great Britain that shows some evidence of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback